← Leaderboards
Alan Cheng
Johns Hopkins University
$4,668,843
Attributed
$6,222,529
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $796.3K · FY2010–19$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$6,222,529 · 2
By mechanism
R01$6,222,529 · 2
Top collaborators
- Eliseo Guallar4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Natalia A. Trayanova$20,674,312
- Henry R Halperin$35,491,139
- Saman Nazarian$4,074,234
- Gordon Frank Tomaselli$21,784,029
- Katherine C Wu$5,117,618
Others in their field
Top investigators on “United States”
- Leonard Freedman · Leidos Biomedical Research, Inc.$818,172,357
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$638,373,375
- David Heimbrook · Leidos Biomedical Research, Inc.$632,657,800
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United StatesCessation Of LifeImplantSample SizeCohort StudiesImplantable DefibrillatorsFollow-UpHigh RiskParticipantPublic Health RelevanceAffectCohortAlgorithmsMyocardial InfarctionCharacteristicsEventArrhythmiaBiologyAdjudicationBiological AvailabilityBaseCase ControlCell PhysiologyCardiomyopathies
Grant awards (9)
MAESTRO-PAF for Major Adverse Events and Stroke in Paroxysmal Atrial Fibrillation$758,063
R01 · FY2019 · HL
MAESTRO-PAF for Major Adverse Events and Stroke in Paroxysmal Atrial Fibrillation$761,455
R01 · FY2018 · HL
MAESTRO-PAF for Major Adverse Events and Stroke in Paroxysmal Atrial Fibrillation$791,567
R01 · FY2017 · HL
MAESTRO-PAF for Major Adverse Events and Stroke in Paroxysmal Atrial Fibrillation$796,287
R01 · FY2016 · HL
Metabolome-wide anaysis for the risk-stratification of sudden cardiac death$620,251
R01 · FY2014 · HL · contact PI
Metabolome-wide anaysis for the risk-stratification of sudden cardiac death$602,745
R01 · FY2013 · HL · contact PI
Metabolome-wide anaysis for the risk-stratification of sudden cardiac death$605,658
R01 · FY2012 · HL · contact PI
Metabolome-wide anaysis for the risk-stratification of sudden cardiac death$625,705
R01 · FY2011 · HL · contact PI
Metabolome-wide anaysis for the risk-stratification of sudden cardiac death$660,798
R01 · FY2010 · HL · contact PI